The hazards of FDI in pharma biz in India
BY Raj Ramachandran & Manav Raheja
The challenge for foreign investors and Indian promoters is to determine whether and how to structure investment terms in order to comply with new conditions, without diluting their commercial considerations.
It’s not every day that a movie star appears before a parliamentary committee to debate on the issue of regulating foreign direct investment into the country. And if that movie star happens to be Aamir Khan,...
Already registered? Login
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.